Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia
Status:
Completed
Trial end date:
2018-12-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of TAK-831 versus placebo on upper
extremity (arm and hands) motor function and manual dexterity. This study will also evaluate
the efficacy of TAK-831 versus placebo on activities of daily living (ADL) and other
secondary assessments.